In this single centre study, three adult patients with MNGIE received intravenous escalating doses of erythrocyte encapsulated thymidine phosphorylase (EE-TP; dose range: 4 to 108 U/kg/4 weeks). This evidence concerns the gene TYMP and mitochondrial neurogastrointestinal encephalomyopathy.